Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 18;24(1):208.
doi: 10.1186/s12883-024-03696-y.

Exploring the lived experiences of individuals with Parkinson's disease and their relatives: insights into care provision experiences, disease management support, self-management strategies, and future needs in Germany (qualitative study)

Affiliations

Exploring the lived experiences of individuals with Parkinson's disease and their relatives: insights into care provision experiences, disease management support, self-management strategies, and future needs in Germany (qualitative study)

Theresia Krieger et al. BMC Neurol. .

Abstract

Background: Parkinson's disease (PD) significantly impacts the health-related quality of life of affected individuals and their relatives. In order to support the affected individuals and their families in coping with PD, it is essential to offer comprehensive information about their experiences. A comprehensive understanding of their lived experiences with the disease, the healthcare system, applied self-management strategies and their needs is considered crucial for developing a PD support program. Therefore, we aimed to explore the lived experiences and support needs of individuals with PD and their relatives in Germany.

Methods: This non-interventional, qualitative study conducted an explorative status quo and needs assessment. It generated knowledge through semi-structured focus groups and interviews with individuals with PD at various disease stages and their relatives. The interviews were digitally recorded, transcribed verbatim, and analysed using content analysis.

Results: Fifty-two individuals with PD and 29 relatives participated in eight focus groups and 13 paired and 13 individual interviews. Four themes with corresponding subthemes emerged: (1) experiences, revealing individuals' experiences around their diagnosis and with disease-specific care provision; (2) management support offers, clarifying who provides support and the type of support offered; (3) self-management, including comprehensibility, meaningfulness and manageability; and (4) future needs, differentiating between deficits and needs. Most participants expressed a sense of abandonment when obtaining self-management strategies and mastering their lives with PD, often referred to as 'life 2.0'. They identified the lack of structured and adequate provision of information, system orientation and social awareness.

Conclusions: In Germany, there is an urgent need for a comprehensive PD care program that addresses the needs of individuals with PD and their relatives from the start of their care trajectory. It could assist individuals in gaining a comprehensive understanding of the disease, obtaining self-management strategies, building a support network, and becoming experts in self-managing their disease. Moreover, it may positively influence their care trajectory and reduce burdens, such as overburdening, fear of progression, and health anxiety.

Trial registration: German Clinical Studies Register ( https://www.drks.de/DRKS00030090 , No. DRKS00030090, Date of registration: 15.12.2022).

Keywords: Experiences of illness; Informational needs; Lived experience; Management support needs; Parkinson’s disease; Qualitative research; Relatives; Self-management.

PubMed Disclaimer

Conflict of interest statement

The authors TK, LJ, GE, TS, NF, TF, CE, TW, WS, CSH and ÜSS declare they have no competing interests.EK has received grants from the German Ministry of Education and Research, the German General Joint Committee, the German Parkinson Society, and STADAPHARM GmbH (Berlin, Germany) as well as honoraria from AbbVie GmbH (Ludwigshafen, Germany) and memodio GmbH (Potsdam, Germany) and license fees from Prolog GmbH (Landau, Germany). EK is one of the authors of the cognitive intervention series “NEUROvitalis” but receives no corresponding honoraria.AKF has received grants from the German Parkinson Society, the German Alzheimer’s Society, the German Parkinson Foundation, STADAPHARM GmbH and the German General Joint Committee, as well as honoraria from Springer Medizin Verlag GmbH (Heidelberg, Germany), Springer-Verlag GmbH (Berlin, Germany), ProLog Wissen GmbH (Cologne, Germany), Seminar- und Fortbildungszentrum (Rheine, Germany), LOGOMANIA, Fendt & Sax GbR (Munich, Germany), LOGUAN (Ulm, Germany), dbs e.V. (Moers, Germany), STADAPHARM GmbH (Bad Vilbel, Germany), NEUROPSY (St. Konrad, Austria), Multiple Sclerosis Society Vienna (Vienna, Austria), and Gossweiler Foundation (Bern, Switzerland). AKF is one of the authors of the cognitive intervention series ‘NEUROvitalis’ but receives no corresponding honoraria.

References

    1. Tolosa E, Garrido A, Scholz SW, et al. Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol. 2021;20(5):385–97. doi: 10.1016/S1474-4422(21)00030-2. - DOI - PMC - PubMed
    1. Heinzel S, Berg D, Binder S, et al. Do we need to rethink the epidemiology and Healthcare utilization of Parkinson’s Disease in Germany? Front Neurol. 2018;9:500. doi: 10.3389/fneur.2018.00500. - DOI - PMC - PubMed
    1. Zhao N, Yang Y, Zhang L, et al. Quality of life in Parkinson’s disease: a systematic review and meta-analysis of comparative studies. CNS Neurosci Ther. 2021;27(3):270–79. doi: 10.1111/cns.13549. - DOI - PMC - PubMed
    1. Rutten S, van den Heuvel OA, de Kruif AJTCM, et al. The subjective experience of living with Parkinson’s Disease: a Meta-ethnography of qualitative literature. J Parkinsons Dis. 2021;11(1):139–51. doi: 10.3233/JPD-202299. - DOI - PMC - PubMed
    1. Khoo TK, Yarnall AJ, Duncan GW, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology. 2013;80(3):276–81. doi: 10.1212/WNL.0b013e31827deb74. - DOI - PMC - PubMed

MeSH terms